This article explores how challenges such as sequence optimization, immune activation and off-target effects are being ...

When a neuron in our body gets damaged, segments of RNA produce proteins that can help repair the injury. But in neurological disorders such as ALS and spinal muscular atrophy, or following spinal ...

This work was supported by funding from New Zealand Ministry of Business Innovation and Employment, Research Trust of Victoria University of Wellington and The Hugh Green Foundation. The recent award ...

Johns Hopkins University, home to considerable expertise in RNA sciences and therapeutic development, has announced a new academic collaboration with TriLink BioTechnologies, part of Maravai ...

RNA technology has had its own Big Bang event. It occurred just a couple of years ago when, seemingly out of nothing, the mRNA-based COVID-19 vaccines appeared. Well, they only seemed to come out of ...

A new RNA type, smOOPs, has been found to drive biomolecular condensate formation in early development, offering new insight ...

Penn Commons at the University of Pennsylvania (Mark Henninger/Imagic Digital) Cellular-level biology that could help develop vaccines just got more accessible to researchers, thanks to AI. The ...

The global RNA therapeutics and vaccines market size was valued at USD 0.21 billion in 2024 and is predicted to hit around ...

< Photo 1. (From left) Professor Won Do Heo and Jihwan Yu, a Ph.D. Candidate of the Department of Biological Sciences > CRISPR-Cas13, a powerful RNA-targeting technology is gaining increasing ...

MONTREAL--(BUSINESS WIRE)--AmorChem II Fund L.P. (''AmorChem'') is delighted to announce that its RNA Zipcode delivery program has been acquired by Kodikaz Therapeutic Solutions, Inc. (''Kodikaz''), a ...

New solutions to previously uncontrolled pests, improved application efficicacy and climate resilience are all benefits Ryan Rapp, CEO and co-founder of Terrana Biosciences, says are possible. The ...